Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / NASDAQ BIOTECH
-
Total 13F shares
-
504,909
-
Share change
-
-163,932
-
Total reported value
-
$10,668,000
-
Price per share
-
$20.93
-
Number of holders
-
10
-
Value change
-
-$3,705,977
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of INVESCO EXCH TRADED FD TR II - NASDAQ BIOTECH (IBBQ) as of Q1 2022
As of 31 Mar 2022,
INVESCO EXCH TRADED FD TR II - NASDAQ BIOTECH (IBBQ) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
504,909 shares.
The largest 10 holders included
Mirae Asset Global Investments Co., Ltd., ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), Clarius Group, LLC, Apexium Financial, LP, Capital Investment Advisory Services, LLC, BANK OF AMERICA CORP /DE/, UBS Group AG, MORGAN STANLEY, and Ahrens Investment Partners LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.